...
首页> 外文期刊>The American journal of orthopedics >Biology, classification, and management of recurrent myxofibrosarcoma 21 years after resection.
【24h】

Biology, classification, and management of recurrent myxofibrosarcoma 21 years after resection.

机译:切除后21年复发性粘膜纤维肉瘤的生物学,分类和处理。

获取原文
获取原文并翻译 | 示例

摘要

Soft-tissue sarcomas (STSs) are a heterogenous group of rare malignancies that have significant lifelong implications. Accepted management options include limb-sparing surgical resection and adjuvant radiation therapy. Here we present the case of a myxoid malignant fibrous histiocytoma, now termed a myxofibrosarcoma, which recurred 21 years after primary surgical resection. To our knowledge, this is the longest documented interval between initial management and recurrence of an STS. Significant changes have been made in classification guidelines and diagnostic methods over this 2-decade period. The pathogenesis of remote recurrence of STSs remains controversial and is discussed in this report.
机译:软组织肉瘤(STS)是罕见的恶性肿瘤的异质性组,具有重要的终身意义。可接受的管理选择包括保留肢体的手术切除和辅助放射治疗。在这里,我们介绍了一种粘液样恶性纤维组织细胞瘤的病例,现在称为粘膜原纤维肉瘤,该病在一次外科手术切除后21年复发。据我们所知,这是STS初始管理和复发之间记录的最长间隔。在过去的两个十年中,分类指南和诊断方法已发生重大变化。 STS远程复发的发病机制仍存在争议,本报告对此进行了讨论。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号